![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 26, 2017 10:35:50 AM
Thesis Update:
TherapeuticsMD (TXMD, BUY, PT $18) Compounding Pharmacy Tour: TX-001 Market Opportunity Is Under-Appreciated - Investor tour of local compounding pharmacy provided unique insights into '001 market opportunity and reinforced our view that the bioidentical E+P VMS market is at a minimum 5.1M scrips or $714-$893M in sales (assumes 100% conversion of scrips). Bear thesis is '001 is a $50M product at peak; we disagree. TXMD is also leveraging similar strategy that grew Makena from $12M in sales to a $250M+ drug, a positive in our view. TXMD is a top small-cap pick for 2017
Recent TXMD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:40:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 10:18:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 09:16:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:10:09 PM
- TherapeuticsMD Announces Second Quarter 2024 Financial Results • Business Wire • 08/12/2024 08:05:00 PM
- Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 06/14/2024 09:00:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:18:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:15:43 PM
- TherapeuticsMD Announces First Quarter 2024 Financial Results • Business Wire • 05/10/2024 08:05:00 PM
- TherapeuticsMD Announces Full Year 2023 Financial Results • Business Wire • 03/29/2024 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:51:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 04:36:35 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/17/2023 02:28:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 02:27:23 PM
- TherapeuticsMD Announces Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM